.RESEARCH FEATURE.06 August 2024.
A huge randomized controlled trial along with cisgender ladies highlights the difficulties of adherence to a day-to-day dental preexposure prophylaxis routine and displays that twice-yearly treatment of lenacapavir can keep reliable HIV deterrence amounts over 6 months.